ConsultantLive Members: Login | Register
 |  |
ConsultantLive SearchMedica Medline Drugs

Powered by SearchMedica

 
About Us
Blogs
Dermclinic
Photoclinic
Pediatric Center
Multimedia
Topics
What's Your Diagnosis?
 

Home » Otorhinolaryngologic Diseases

ConsultantLive.com. Vol. 50 No. 2
Pages: 1  2  
Previous
What's The “Take Home”?
Pearls From Clinical Cases 

Epistaxis in a 62-Year-Old Woman

By RONALD N. RUBIN, MD—Series Editor | February 17, 2010
Dr Rubin is professor of medicine at Temple University School of Medicine and chief of clinical hematology in the department of medicine at Temple University Hospital, both in Philadelphia.

CORRECT ANSWER: B

Epistaxis is one of the most common nontraumatic bleeding events encountered in clinical medicine. As many as 60% of persons experience epistaxis in their lifetime, and about 6% of them present for medical evaluation.1 Peak ages are younger than 10 years and older than 40 years.1

Factors that contribute to epistaxis in otherwise healthy persons. These include nose picking (in children); certain environmental conditions (eg, dry heat in winter); viral URTIs with frequent nose blowing and sneezing; and use of topical nasal sprays/medications.

Systemic conditions that can cause epistaxis. Several more serious systemic conditions have also been suspected to cause epistaxis. Hypertension (choice C) has long been thought to be a major epidemiological factor in epistaxis. However, more current data indicate that any causal association is weak at most.2,3 A prospective study showed that in hypertensive patients, epistaxis incidence was not related to hypertension severity,1 and a population-based study showed no association at all.3 Although earlier studies documented hypertension in many patients with epistaxis, the blood pressure elevations may have been the result of stress and anxiety produced by the episode rather than the cause of it.

Coagulopathies. There is stronger evidence of a causal role for coagulopathy in epistaxis. A recent retrospective study reported that 45% of patients admitted for epistaxis (a subgroup with more severe epistaxis) had systemic disorders with associated coagulopathy.4 These conditions included ingestion of anticoagulants or antiplatelet agents, significant hepatic or renal disease, and previously undiagnosed coagulation disorders.

It is unlikely that this patient has an undiagnosed coagulation disorder, such as von Willebrand disease (choice A). She is 62 and has no previous bleeding history, even in the setting of such hemostatic challenges as childbirth, major surgery, and extraction of permanent teeth. Moreover, her PT and PTT are normal.

However, she has just started ASA therapy. A recent large study evaluating ASA for cardiovascular prophylaxis showed a slight but definite increased risk of epistaxis in patients receiving ASA compared with matched patients not receiving ASA (19.1% vs 16.7%).5 Moreover, this patient has not been using the recommended 81-mg daily dose but a higher dose (325 mg), which has been shown not to enhance cardiovascular prophylaxis but to increase the risk of bleeding.6 Her bleeding time is at the upper limit of normal, and she has several bruises. Thus, her ASA use (choice B)—particularly in the setting of a URTI—is most likely responsible for this episode of epistaxis.

Local pathologies. Several types of local pathology can also present as epistaxis. Hereditary hemorrhagic telangiectasia (choice D) is an autosomal dominant genetic defect of blood vessels that renders the mucosal capillaries fragile and prone to hemorrhage. Mucosal bleeding, especially epistaxis and GI bleeding, is the main manifestation; bleeding episodes typically recur lifelong, resulting in anemia and severe iron deficiency. The capillary telangiectasia can be visualized on endoscopy. Onset is in the second and third decades of life.

Outcome of this case. Physical examination, including nasal endoscopy, revealed no significant local pathology. Topical vasoconstrictors and moisturizing ointments were applied, and the bleeding ceased. Packing was not required. ASA was discontinued for a week, then restarted at a dosage of 81 mg/d. After 4 months, epistaxis has not recurred.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Morgan Kelsey | February 26, 2010 5:43 PM EST

Thanks for letting us know, the links in this article have been corrected.

by Frank Medford | February 19, 2010 1:57 PM EST

The CME printout is not the same title as the subject or posttest.  Frank E. Medford. M. D.





REFERENCES:
1. Schlosser RJ. Clinical practice. Epistaxis. N Engl J Med. 2009;360:784-789.
2. Gifford TO, Orlandi RR. Epistaxis. Otolaryngol Clin North Am. 2008;41: 525-536, viii.
3. Fuchs FD, Moreira LB, Pires CP, et al. Absence of association between hypertension and epistaxis: a population-based study. Blood Press. 2003;12:145-148.
4. Awan MS, Iqbal M, Imam SZ. Epistaxis: when are coagulation studies justified? Emerg Med J. 2008;25:156-157.
5. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293-1304.
6. Becker RC, Meade TW, Berger PB, et al; American College of Chest Physicians. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 suppl):776S-814S.


 
TOPIC INDEX

Asthma

Atrial Fibrillation

Cardiovascular

Cerebrovascular

Developmental/Genetic

Diabetes

Diabetes Type 2

Fibromyalgia

Geriatrics

GI Disorders

Gout

Health Care Reform

HIV/AIDS

Hypertension

Infection

Mental Health

 

Musculoskeletal

Nervous System

Nutritional/Metabolic 

Otorhinolaryngologic 

Pain

Pediatrics

Physical Abuse

Respiratory Tract 

Rheumatic Diseases

Seasonal Allergies

Skin Diseases

Sleep Disorders

Urologic Diseases

Vaccines

Women’s Health

All Topics

 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Painful Red Ear
  • Facial Skin Problems—A Photo Essay
  • Go For The Glory Quiz: Persistent Oral Lesions, Nevus or Melanoma?, Altered Mental Status in Middle Age, An Itchy, Scaly Rash, Painful Blisters of the Hand
  • Scaly Plaque on the Nose
  • T-Wave Inversions: Sorting Through the Causes
  • Tuberculosis Diagnosis With Handheld Device
  • Physician, First Do No Harm—To Yourself
  • Making the Most of Antihypertensive Drug Combinations
  • Why Doctors Commit Suicide
  • Superficial Abrasion After a Fall From a Bicycle
  • Women Underrepresented in Antiretroviral Clinical Trials
  • Crohn’s Disease: New Scoring System Predicts Mild Disease
  • Iron-deficiency Anemia in IBD: These Patients Need Primary Care
  • Statins Plus Exercise: New Study Questions the Combination
  • Benign Congenital Nevus
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Nodular Basal Cell Carcinoma
  • Short on Physicians, Long on Adverse Effects
  • Wanted: Physician Feedback on Medical Cannabis
  • Why Doctors Commit Suicide
  • Crusted Scabies
  • Scaly Plaque on the Nose
  • Short on Physicians, Long on Adverse Effects
  • Furuncle Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
  • Resistant Hypertension: Four Pearls for Your Practice
  • Nodular Basal Cell Carcinoma
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Otorhinolaryngologic Diseases
Evidence on Otorhinolaryngologic Diseases
Guidelines on Otorhinolaryngologic Diseases
Patient Education on Otorhinolaryngologic Diseases
Clinical Trials on Otorhinolaryngologic Diseases
Practical Articles on Otorhinolaryngologic Diseases
Research and Reviews on Otorhinolaryngologic Diseases
All "Otorhinolaryngologic Diseases" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy